| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.084 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.072 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |